This program, which began more than 34 years ago, brings together investigators from multiple disciplines with an interest in the integrative aspects of circulatory function. Our major long-term goal has been to develop a quantitative analysis of circulatory dynamics and related control systems, including the kidneys, sympathetic nervous system, and endocrine systems. Two unique features of this program are: 1) it utilizes an integrative approach to understand complex interactions between multiple components of cardiovascular control systems, and 2) it focuses mainly on long-term control of the circulation because many cardiovascular diseases, such as hypertension, are manifestations of abnormal control mechanisms that develop slowly over long periods of time. The research proposed in this application is described by the titles of the specific projects as follows: I. Neurohumoral and Renal Mechanisms of Hypertension; this project will elucidate the neurohumoral and intrarenal mechanisms that contribute to the pathogenesis of obesity hypertension, which is of special relevance to human essential hypertension. II. Renal Control of Body Fluid Volumes and Circulatory Dynamics; this project will define the interaction between endothelin, oxidative stress and tumor necrosis factor in mediating altered renal-pressure natriuresis and hypertension in response to chronic reductions in uterine perfusion pressure in pregnant rats. III. Mechanisms of Salt-Sensitive Hypertension; this project will test the hypothesis that an increase in reactive oxygen species and a decrease in antioxidant mechanisms in the kidney play a major role in the development of salt-sensitive hypertension and associated renal injury. IV. Neural Mechanisms in Cardiorenal Regulation; this project will test the hypothesis that sustained activation of the baroreflex attenuates hypertension by suppressing renal sympathetic activity and promoting sodium excretion, and that these effects are mediated, in part, via suppression of the renin-angiotensin system. V. Role of Humoral Factors in Postmenopausal Hypertension; this project will test the hypothesis that post-menopausal hypertension in rats is caused by impaired renal-pressure-natriuresis mediated by activation of the renin-angiotensin system, and subsequent increases in endothelin and oxidative stress that are due, in part, to increases in serum testosterone. The total program, including core support services, provides a unique interdisciplinary approach toward developing an integrative analysis of long-term regulation of blood pressure and circulatory dynamics in several forms of experimental hypertension that have great relevance to human hypertension.
| Eddy, Adrian C; Bidwell 3rd, Gene L; George, Eric M (2018) Pro-angiogenic therapeutics for preeclampsia. Biol Sex Differ 9:36 |
| do Carmo, Jussara M; da Silva, Alexandre A; Moak, Sydney P et al. (2018) Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia. Acta Physiol (Oxf) :e13222 |
| Lindsey, Merry L; Bolli, Roberto; Canty Jr, John M et al. (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812-H838 |
| Chen, Xu; Li, Xuan; Zhang, Wenyan et al. (2018) Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-?B pathway. Metabolism 83:256-270 |
| Ma, Yonggang; Mouton, Alan J; Lindsey, Merry L (2018) Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res 191:15-28 |
| Mouton, Alan J; DeLeon-Pennell, Kristine Y; Rivera Gonzalez, Osvaldo J et al. (2018) Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol 113:26 |
| Meschiari, Cesar A; Jung, Mira; Iyer, Rugmani Padmanabhan et al. (2018) Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction. Am J Physiol Heart Circ Physiol 314:H224-H235 |
| Hinds Jr, Terry D; Stec, David E (2018) Bilirubin, a Cardiometabolic Signaling Molecule. Hypertension 72:788-795 |
| Adeosun, Samuel O; Moore, Kyle H; Lang, David M et al. (2018) A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity. React Oxyg Species (Apex) 5:35-45 |
| Hall, Michael E; Jordan, Jennifer H; Juncos, Luis A et al. (2018) BOLD magnetic resonance imaging in nephrology. Int J Nephrol Renovasc Dis 11:103-112 |
Showing the most recent 10 out of 767 publications
